Loading…
In Vivo Kinetics and Biotransformation of Aflatoxin B1 in Dairy Cows Based on the Establishment of a Reliable UHPLC-MS/MS Method
The in vivo kinetics of aflatoxin B 1 (AFB 1 ) and its carry-over as aflatoxin M 1 (AFM 1 ) in milk as well as the toxin loads in the tissue of dairy cows were assessed through a repetitive feeding trial of an AFB 1 -contaminated diet of 4 μg kg −1 body weight (b.w.) for 13 days. This was followed b...
Saved in:
Published in: | Frontiers in chemistry 2021-12, Vol.9, p.809480-809480 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The
in vivo
kinetics of aflatoxin B
1
(AFB
1
) and its carry-over as aflatoxin M
1
(AFM
1
) in milk as well as the toxin loads in the tissue of dairy cows were assessed through a repetitive feeding trial of an AFB
1
-contaminated diet of 4 μg kg
−1
body weight (b.w.) for 13 days. This was followed by a clearance period that ended with a single dose trial of an AFB
1
-contaminated diet of 40 μg kg
−1
b.w. An ultra-high performance liquid chromatography tandem mass spectrometry method was developed and successfully validated by the determination of linearity (
R
2
≥ 0.990), sensitivity (lower limit of quantification, 0.1–0.2 ng ml
−1
), recovery (79.5–111.2%), and precision relative standard deviation (RSD) ≤14.7%) in plasma, milk, and various tissues. The repetitive ingestion of AFB
1
indicated that the biotransformation of AFB
1
to AFM
1
occurred within 48 h, and the clearance period of AFM
1
in milk was not more than 2 days. The carry-over rate of AFM
1
in milk during the continuous ingestion experiment was in the range of 1.15–2.30% at a steady state. The
in vivo
kinetic results indicated that AFB
1
reached a maximum concentration of 3.8 ± 0.9 ng ml
−1
within 35.0 ± 10.2 min and was slowly eliminated from the plasma, with a half-life time (T
1/2
) of 931.1 ± 30.8 min. Meanwhile, AFM
1
reached a plateau in plasma (0.5 ± 0.1 ng ml
−1
) at 4 h after the ingestion. AFB
1
was found in the heart, spleen, lungs, and kidneys at concentrations of 1.6 ± 0.3, 4.1 ± 1.2, 3.3 ± 0.9 and 5.6 ± 1.4 μg kg
−1
, respectively. AFM
1
was observed in the spleen and kidneys at concentrations of only 0.7 ± 0.2 and 0.8 ± 0.1 μg kg
−1
, respectively. In conclusion, the
in vivo
kinetics and biotransformation of AFB
1
in dairy cows were determined using the developed UHPLC-MS/MS method, and the present findings could be helpful in assessing the health risks to consumers. |
---|---|
ISSN: | 2296-2646 2296-2646 |
DOI: | 10.3389/fchem.2021.809480 |